Effects of Procainamide and N-Acetylprocainamide on Myocardial Contractility in Ischemic Isolated Rabbit Hearts
- 1 December 1981
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 168 (3) , 350-355
- https://doi.org/10.3181/00379727-168-41285
Abstract
While many antiarrhythmic drugs depress myocardial function, N-acetylprocainamide, the major metabolite of procainamide, appears to improve myocardial performance in vivo. The present study compared the effect of procainamide with N-acetylprocainamide on the isolated, perfused, globally ischemic rabbit heart. Procainamide depressed dPldt at infusion rates of 2 mg/min or greater. N-Acetylprocainamide depressed dP/dt at infusion rates of 40 mg/min or greater and may have increased dP/dt at low rates of around 1 mg/min. Pretreatment of the rabbits with reserpine abolished any increase in dPldt produced by N-acetylprocainamide. We conclude that N-acetylprocainamide does not have intrinsic direct positive inotropic activity in this model.This publication has 6 references indexed in Scilit:
- Effects of N-Acetylprocainamide and Procainamide on Myocardial Contractile Force, Heart Rate, and Blood PressureExperimental Biology and Medicine, 1979
- Long‐term antiarrhythmic therapy with N‐acetylprocainamideClinical Pharmacology & Therapeutics, 1979
- Ventricular Premature Beats and Mortality after Myocardial InfarctionNew England Journal of Medicine, 1977
- Dose‐ranging trial of N‐acetylprocainamide in patients with premature ventricular contractionsClinical Pharmacology & Therapeutics, 1977
- Sudden death in the year following myocardial infarctionThe American Journal of Medicine, 1977
- A model of graded ischemia in the isolated perfused rat heartJournal of Applied Physiology, 1976